Bloomberg News

Novo Says Victoza Is Available for Type 2 Diabetes in China

October 10, 2011

Oct. 10 (Bloomberg) -- Novo Nordisk A/S said Victoza is now commercially available in China after it was approved for type 2 diabetes by the Chinese State Food and Drug Administration on March 15, according to an e-mail statement today.

To contact the editor responsible for this story: Christian Wienberg at cwienberg@bloomberg.net


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus